Yanan Bicon Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Special Reminder:
-
The Company's stock has been decided to be terminated from listing by the Shenzhen Stock Exchange. The stock entered the delisting preparation period on June 19, 2023, trading for fifteen trading days, with the last trading day being July 11, 2023.
-
The stock will be delisted on July 12, 2023.
-
After the termination of listing, the stock will enter the delisting section managed by the National Equities Exchange and Quotations for transfer. The main broker, Shanxi Securities Co., Ltd., will issue an announcement regarding the confirmation of shares, registration, and custody procedures after delisting.
-
Investors are advised to continuously pay attention to notifications from the custody broker and announcements from the main broker regarding share confirmation, and to contact the custody broker or main broker promptly to complete share confirmation procedures and handle transaction settlement procedures such as opening capital accounts.
On June 9, 2023, Yanan Bicon Pharmaceutical Co., Ltd. received the "Decision on the Termination of Listing of Yanan Bicon Pharmaceutical Co., Ltd. Stock" (Shenzhen Stock Exchange [2023] No. 487) issued by the Shenzhen Stock Exchange. Given that the Company's stock has been decided to be terminated from listing, according to the relevant provisions of the "Shenzhen Stock Exchange Stock Listing Rules (2023 Revision)" and the "Implementation Measures for Delisted Companies Entering the Delisting Section for Transfer," the Company must promptly carry out relevant work after the stock is terminated from listing to ensure that the shares can enter the delisting section managed by the National Equities Exchange and Quotations for transfer within forty-five trading days after delisting.